Latest Profitability News

Kogan.com (ASX:KGN) crossed $1 billion in annual gross sales as stronger margins, cash generation and a Mighty Ape reset lifted FY26 results. The group returned to statutory profit, ended debt-free and declared another fully franked dividend.

RMA Global has replaced its chief executive and moved to a new chair as it targets a simpler, faster and more profitable business across Australia, New Zealand and the United States. The company has set an EBITDA improvement objective for FY27, but has not yet quantified the plan.

Lycopodium has won an approximately A$42.9 million engineering and procurement contract for Endeavour Mining’s Assafo-Dibibango gold project in Côte d’Ivoire. Work has begun, but continued execution and full implementation remain conditional on Endeavour approving its final investment decision, expected before the end of 2026.

GDI Property Group (ASX:GDI) lifted FY26 Funds From Operations by 25% to $44.5 million while reducing gearing to 33% and maintaining its 5.00 cents per security distribution. The annual report also sets out a buyback of up to 5% of stapled securities, but says completing the programme may depend on further asset sales.

The Hydration Pharmaceuticals Company (ASX:HPC) has sharply reduced its operating losses, with Hydralyte LLC recording its first monthly EBITDA profit in August. The group remains loss-making overall, but improved margins and a lower cost base are beginning to show in the numbers.

Temple & Webster delivered record FY26 revenue of $664.6 million and lifted underlying EBITDA by 28%, despite a sharp fall in statutory profit after tax. The online retailer is targeting EBITDA of $33 million to $40 million in FY27 as improved margins, exclusive products and adjacent categories do more of the heavy lifting.

Codan expects first-half FY27 net profit after tax of at least $160 million, powered by a sharp increase in Communications revenue and margins. The company is raising its full-year Communications growth target, while warning that conflict-region demand remains difficult to forecast beyond three months.

Cochlear is defending a class action filed in the Supreme Court of Victoria over its FY26 underlying net profit forecast. The claim covers investors who acquired interests in Cochlear shares between 15 August 2025 and 21 April 2026.

Firebrick Pharma has approved a phased push into US retail pharmacies after Nasodine online sales grew by more than 200% in FY26. Up to six regional pharmacy groups representing about 700 stores have expressed strong interest in early orders, although no binding orders have been disclosed.

Structural Monitoring Systems (ASX:SMN) delivered record FY26 revenue, a sharp lift in profit and $6.0 million of free cash flow as its avionics business outpaced contract manufacturing. The balance sheet is now free of bank debt, but the next leg of the story still depends on FAA approvals and converting CVM technology into commercial revenue.

Carnarvon Energy has expanded its Bedout prospective resource inventory by 92% and secured a rig for a 2027 exploration campaign, but Dorado remains stalled before FEED and FID. The company ended FY26 with A$97.7 million in cash, no debt and a A$4.2 million after-tax loss.

Arena REIT delivered higher earnings, distributions and asset values in FY2026, but the failure of a major childcare tenant has forced a sharp reset in its near-term outlook. Edge Early Learning accounts for about 14% of rental income and is now in voluntary administration after missing rent.